People living with CTEPH face significant symptoms that affect daily life, even when receiving treatment, a real-world U.S.

Early diagnosis of pulmonary arterial hypertension improves five-year survival by 42%, compared with delayed diagnosis, a ...

Instead of resolutions, columnist Jen Cueva suggests a strategy that better reflects the reality of living with a rare disease like PH.

Researchers in China report that a simple heart ultrasound measure of left ventricular underfilling is a valuable prognostic ...

A study found that pulmonary hypertension often resolves within a year in premature infants with BPD, though many still ...

Researchers have pinpointed Jagged-2, a signaling protein, as a potential therapeutic target for slowing or halting the progression of pulmonary arterial hypertension (PAH), based on a rat study.

Two Phase 3 clinical trials are now recruiting participants to test Tenax Therapeutics‘ experimental therapy TNX-103 (oral levosimendan) in people with pulmonary hypertension associated with heart ...

Uptravi (selexipag) may reduce blood pressure in the lungs of children with pulmonary arterial hypertension (PAH) and help them perform physical tasks, according to a meta-analysis. However, more long ...

Just as life seemed to be moving smoothly for me and a new treatment was showing promise, I unexpectedly found myself “on vacation” at my local hospital. For those of us navigating the complicated ...

During the holidays, I love spending time in the kitchen, using all my favorite devices to bake cookies and other treats that remind me of past Christmas celebrations. With a stand mixer, food ...

A committee of the European Medicines Agency (EMA) has recommended expanding the indication for Winrevair (sotatercept-csrk), Merck’s approved injection therapy for adults with pulmonary arterial ...